C9 and amyotrophic lateral sclerosis: Moreover, higher p-NfH levels were associated with faster disease progression and shorter survival both into this subset of patients and when comparing C9-ALS patients with asymptomatic carriers and with non-C9Orf72 mutation carriers, likely reflecting an increased neuronal injury in C9-ALS patients.